As shown in Figure 9, higher expression levels of EGFR and ITGA3 were discovered in patients with HPV-negative HNSCC, while higher CDKN2A expression was found in patients with HPV-positive HNSCC. Here, CDKN2A is linked to head and neck squamous cell carcinoma.